Search
Please choose your country
more info

Contact:
Phone:+49 0761 1514 440 Fax:+49 0761 1514 460 Email: info@falkfoundation.org

Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 2/2026

Edition 1/2026

Edition 4/2025

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Liver and Bile

Noncontrast magnetic resonance imaging vs. ultrasonography for hepatocellular carcinoma surveillance: A randomized, single-center trial

Gastroenterology. 2025;168(6):1170-1177.e12

Rhee H, Kim MJ, Kim DY, An C, Kang W, Han K, Roh YH, Han KH, Ahn SH, Choi JY, Park JY, Chung YE, Kim SU, Kim BK, Lee S, Lee HW, Lee JS

Esophagus to Small Intestine

All-cause and cause-specific mortality in achalasia: A nationwide matched cohort study

Clin Gastroenterol Hepatol. 2025;23(13):2468-2476.e7

Forss A, Hansson MR, Holmberg D, Thuresson M, Ebrahimi F, Elbe P, Klevebro F, Håkanson B, Thorell A, Ludvigsson JF

Esophagus to Small Intestine

Pancreatic exocrine insufficiency is not uncommon in celiac disease: A systematic review and meta-analysis

United European Gastroenterol J. 2025;13(7):1107-1115

Vujasinovic M, Blazevic N, Maisonneuve P, Forss A, Panic N, Bloch N, Dominguez Munoz JE, Ludvigsson JF, Löhr JM

Esophagus to Small Intestine

pH impedance monitoring on proton pump inhibitor therapy impacts management decisions in proven GERD but not in unproven GERD

Clin Gastroenterol Hepatol. 2025;23(13):2459-2467

Prakash Gyawali C, Rogers BD, Yadlapati R, Roman S, Carlson DA, Pandolfino J

Esophagus to Small Intestine

Efficacy and safety of budesonide orodispersible tablets for eosinophilic esophagitis up to 3 years: An open-label extension study

Clin Gastroenterol Hepatol. 2025;23(12):2144-2154.e6

Biedermann L, Schlag C, Straumann A, Lucendo AJ, Miehlke S, Vieth M, Santander C, Ciriza de Los Rios C, Schmöcker C, Madisch A, Hruz P, Hayat J, von Arnim U, Bredenoord AJ, Schubert S, Halstead M, Pfurr S, Mueller R, Schoepfer AM, Attwood S; International EOS-2 Study Group

Esophagus to Small Intestine

Long-term safety and efficacy of budesonide oral suspension for eosinophilic esophagitis: A 4-year, phase 3, open-label study

Clin Gastroenterol Hepatol. 2025;23(12):2155-2166.e5

Dellon ES, Katzka DA, Mukkada VA, Collins MH, Falk GW, Richmond CA, Terreri B, Thakur M, Boules M, Goodwin B, Hirano I

Esophagus to Small Intestine

High risk of persistence and risk of dysplasia after diagnosis of ultrashort Barrett’s esophagus

Am J Gastroenterol. 2025;120(11):2520-2528

Skef W, Haydel J, Rao A, Allencherril R, George R, Ketwaroo GA, Thrift AP, El-Serag HB, Nguyen Wenker T

Esophagus to Small Intestine

Pembrolizumab plus chemotherapy versus chemotherapy as perioperative therapy in locally advanced gastric and gastroesophageal junction cancer: Final analysis of the randomized, phase 3 KEYNOTE-585 study

J Clin Oncol. 2025;43(29):3152-3159

Shitara K, Rha SY, Wyrwicz L, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Pietrantonio F, Lonardi S, Fang X, Guan Y, Valderrama A, Leconte P, Bhagia P, Bang YJ; KEYNOTE-585 Investigators

Esophagus to Small Intestine

Barrett’s oesophagus surveillance versus endoscopy at need study (BOSS): A randomized controlled trial

Gastroenterology. 2025;169(6):1233-1243.e8

Old O, Jankowski J, Attwood S, Stokes C, Kendall C, Rasdell C, Zimmermann A, Massa MS, Love S, Sanders S, Deidda M, Briggs A, Hapeshi J, Foy C, Moayyedi P, Barr H; BOSS Trial Team